companydata.dkcompanydata.dk

VEPIDAN ApS: Financial statements 2022

CVR: 17077848

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

VEPIDAN ApS (CVR 17077848) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 4,469,196 and a net result of DKK -5,785,600 compared with DKK 37,577,490 the year before. That is a decrease of 43.1% compared with the year before. Equity in the 2022 report amounted to DKK 95,736,432. The solvency ratio was 62.8%. The company had 27 employees in the financial year.

Gross Profit
DKK 4,469,196
Profit/Loss
DKK -5,785,600
Equity
DKK 95,736,432
Total Assets
DKK 152,546,866
Employees
27

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-4.5 mio.-5.8 mio.95.7 mio.27
2021-7.8 mio.37.6 mio.101.5 mio.27
2020-9.4 mio.10.6 mio.64.1 mio.23
2019-9.6 mio.4.8 mio.53.7 mio.23
2018-7.9 mio.-2.4 mio.49.1 mio.22

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on VEPIDAN ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About VEPIDAN ApS

VEPIDAN ApS is a Danish company of the type Anpartsselskab based in Løgstør, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ApS KBUS 8 NR. 3163. The management consists of Margarethe Bower. The company is owned by Hans Christian Graversen, Margarethe Bower and Peter Graversen. The company has 37 employees (2026). In 2025, the company reported a gross profit of DKK 5,846,932 and a net result of DKK 2,949,865 compared with DKK -1,241,820 the year before. Equity in the 2025 report amounted to DKK 109,259,532.

Source: annual report 2025, Danish Business Authority